257 related articles for article (PubMed ID: 20419486)
1. Ivabradine: from molecular basis to clinical effectiveness.
Riccioni G
Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
[TBL] [Abstract][Full Text] [Related]
2. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
3. I(f) inhibition in cardiovascular diseases.
Thollon C; Vilaine JP
Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Borer JS; Le Heuzey JY
Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
[TBL] [Abstract][Full Text] [Related]
6. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
Riccioni G
Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921
[TBL] [Abstract][Full Text] [Related]
7. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
Rosano GM; Vitale C; Volterrani M
Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
[TBL] [Abstract][Full Text] [Related]
8. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
Canet E; Lerebours G; Vilaine JP
Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
[TBL] [Abstract][Full Text] [Related]
9. Ivabradine: pharmacodynamic aspects of its clinical use.
Stieber J
Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
[TBL] [Abstract][Full Text] [Related]
10. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
Prasad UK; Gray D; Purcell H
Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.
Joannides R; Moore N; Iacob M; Compagnon P; Lerebours G; Menard JF; Thuillez C
Br J Clin Pharmacol; 2006 Feb; 61(2):127-37. PubMed ID: 16433867
[TBL] [Abstract][Full Text] [Related]
12. Focus on ivabradine: a new heart rate-controlling drug.
Riccioni G
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
[TBL] [Abstract][Full Text] [Related]
13. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
14. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
[TBL] [Abstract][Full Text] [Related]
15. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
[TBL] [Abstract][Full Text] [Related]
16. Heart rate as a treatable cardiovascular risk factor.
Tardif JC
Br Med Bull; 2009; 90():71-84. PubMed ID: 19474056
[TBL] [Abstract][Full Text] [Related]
17. Heart rate reduction via selective 'funny' channel blockers.
Bucchi A; Barbuti A; Baruscotti M; DiFrancesco D
Curr Opin Pharmacol; 2007 Apr; 7(2):208-13. PubMed ID: 17267284
[TBL] [Abstract][Full Text] [Related]
18. The Role of Ivabradine in the Management of Angina Pectoris.
Giavarini A; de Silva R
Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
[TBL] [Abstract][Full Text] [Related]
19. Rate control with ivabradine: angina pectoris and beyond.
Parakh N; Bhargava B
Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
[TBL] [Abstract][Full Text] [Related]
20. Ivabradine: recent and potential applications in clinical practice.
Riccioni G
Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
